CTMX FY 2015 Earnings — CytomX Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CTMXCytomX Therapeutics, Inc.

$827M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+51.9% YoY

Gross Profit

$8M100.0% margin

Operating Income

-$33M-430.5% margin

Net Income

-$35M-458.7% margin

EPS (Diluted)

$-1.00

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$197M

Total Liabilities

$71M

Stockholders' Equity

$126M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+51.9%
Gross Profit	$8M	$5M	+51.9%
Operating Income	-$33M	-$30M	-11.6%
Net Income	-$35M	-$30M	-16.7%